Related Experiment Video

Updated: Jul 15, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

[Apoptotic mechanisms induced in breast cancer cells by vinorelbine]

Hiroo Nakajima1, Koichi Sakaguchi, Naruhiko Mizuta

  • 1Dept. of Endocrine and Breast Surgery, Kyoto Prefectural University of Medicine.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|April 14, 2007
PubMed

Insights

Vinorelbine (VNB), an antimicrotubule agent, effectively induces apoptosis in breast cancer cells. This finding highlights VNB

Area of Science:

  • Oncology
  • Pharmacology
  • Cell Biology

Background:

  • Vinorelbine (VNB) is a semi-synthetic vinca alkaloid with demonstrated efficacy in non-small cell lung cancer and breast cancer.
  • VNB functions as an antimicrotubule agent, interfering with cellular processes like mitosis.
  • Its potential in treating multi-drug resistant tumors is of significant interest.

Purpose of the Study:

  • To investigate the mechanism by which Vinorelbine (VNB) induces cell death in breast cancer.
  • To determine if VNB triggers apoptosis through a mitochondrial pathway in the MX-1 breast cancer cell line.

Main Methods:

  • Utilized the MX-1 breast cancer cell line for experimental studies.
  • Administered Vinorelbine (VNB) to the cell line to observe its effects.
  • Analyzed the cellular response to VNB, focusing on apoptotic pathways, particularly the mitochondrial pathway.

Main Results:

  • Vinorelbine (VNB) was confirmed to act as an antimicrotubule agent.
  • VNB treatment led to the induction of apoptosis in the MX-1 breast cancer cell line.
  • Evidence suggests the involvement of the mitochondrial pathway in VNB-induced apoptosis.

Conclusions:

  • Vinorelbine (VNB) effectively induces apoptosis in breast cancer cells via a mitochondrial pathway.
  • These findings support the potential of VNB as a therapeutic agent for breast cancer, possibly including resistant forms.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...